Eli Lilly & Co. has accused the U.S. Department of Health and Human Services of unlawfully obstructing its initiatives to address alleged double-dipping by hospitals on medication discounts intended for low-income patients. Meanwhile, the U.S. Department of Justice, along with four state attorneys general, has filed a lawsuit to prevent UnitedHealth Group from acquiring Amedisys. The DOJ's complaint presents a detailed argument against the acquisition. Additionally, CVS Health, UnitedHealth Group, and Cigna have initiated a lawsuit against the Federal Trade Commission, asserting that the agency's actions targeting drug middlemen over escalating insulin prices are unconstitutional.